Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Anthony DiPiazza, PhD
Moderna, Inc.
Disclosure(s): Moderna, Inc.: Employee, Stocks/Bonds (Public Company)
Poster(s):
(P-1452) A Seasonal Influenza Hemagglutinin mRNA-Based Vaccine Induces Humoral and Cellular Immunity Comparable to an Adjuvanted Inactivated Influenza Virus Vaccine
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1454) mRNA-Based Respiratory Syncytial Virus Vaccine mRNA-1345 Induces Robust, Polyfunctional, and Durable CD4+ and CD8+ T Cell Responses with Similar Features in Adults Across Age Groups
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
